InnoPharm 2026: 2nd Edition of Innovations in Pharma R&D
Hosted by CO-IN Symposia LLC
- 2 – 4 November 2026
Add to calendar
Welcome to kongre.net - Holiday Inn Boston Hotel, Boston, United States of America
- Health SciencesPharmacy & Pharmaceutical Sciences
Let others know you'll be there. This does not register you for the event.
Registration
Registration is handled by the organiser
Fees are listed on this page
View registration detailsKey facts
InnoPharm 2026: 2nd Edition of Innovations in Pharma R&D is a conference held 2 – 4 November 2026 in Holiday Inn Boston Hotel, Boston, United States of America, organised by CO-IN Symposia LLC.
- Dates:
- 2 – 4 November 2026
- Format:
- Hybrid (in person and online)
- Venue:
- Holiday Inn Boston Hotel, Boston, United States of America
- Subjects:
- Pharmacy & Pharmaceutical Sciences
- Organiser:
- CO-IN Symposia LLC
- Official website:
- pharm-science.com
InnoPharm 2026 is the second edition of the Innovations in Pharma R&D conference, organized by CO-IN Symposia. Taking place from November 2-4, 2026, in Boston, MA, the event brings together leading researchers, industry experts, and emerging innovators for a three-day journey focusing on breakthroughs, collaborations, and technologies driving the next era of global healthcare. The conference features specialized tracks, interactive sessions, and networking opportunities designed to unite academia, industry, and regulatory experts.
Conference theme
Topics
Who should attend
Organising Committee
- CO-IN Symposia Organizing Team
Scientific Committee
- Prof. Debbie C. Crans, Colorado State University
- Prof. Ruben Abagyan, University of California, San Diego, USA
- Dr. Girish Nallur, Vistara Bioscience, USA
- Dr. Urszula Komarnicka, University of Wrocław, Poland
Programme highlights
View full programmeKeynote speakers
View programmeKeynote
Professor, Dana-Farber Cancer Institute, Harvard Medical School
KAT6A/B Inhibitor Transcriptionally Upregulates GD2 to Sensitize Neuroblastoma Cells to Targeted ImmunotherapyKeynote
Professor, Stanford University
The SPARK Model of Translational Research in Academia; a 20 Years ReportKeynote
Professor, Colorado State University
Beyond the Active Species: Transformation Networks in Vanadium Pharmacology2 conferences on kongre.netKeynote
Founding Director & Core Faculty, Wyss Institute at Harvard University
Human Organ Chips for Disease Modeling, Drug Development, and Personalized MedicineKeynote
Professor, Virginia Polytechnic Institute & State University
Rejuvenation of Innate Immunity for Treating Chronic Inflammatory DiseaseKeynote
Professor, Brigham and Women’s Hospital, Harvard Medical School
Epigenetic Inhibitors as Novel Therapeutics: Applications in Cancer and Beyond
Speakers
View all 15 speakersMartin SchwartzKeynote
Yale School of Medicine
A Novel Target for Combating Vascular Inflammatory DiseaseDebbie C. CransKeynote
Colorado State University
Beyond the Active Species: Transformation Networks in Vanadium PharmacologyRhoda AlaniKeynote
Brigham and Women’s Hospital, Harvard Medical School
Epigenetic Inhibitors as Novel Therapeutics: Applications in Cancer and BeyondLudwig-Maximilians-Universität München, Germany
Wyss Institute at Harvard University, Boston, MA
Donald IngberKeynote
Wyss Institute at Harvard University
Human Organ Chips for Disease Modeling, Drug Development, and Personalized MedicineDaria Mochly RosenKeynote
Stanford University
The SPARK Model of Translational Research in Academia; a 20 Years ReportLSU Health New Orleans, New Orleans, LA
Organiser and contact
Contact
- Event secretary:
- Gayatri Srinivas
- Email:
- [email protected]
Advertisement
Related events
- 17th World ADC San DiegoSan Diego, United States of America12–15 Oct 2026
- 4th Covalent Drug Discovery & Development SummitBoston, United States of America20–22 Oct 2026
- 9th TPD & Induced Proximity SummitBoston, United States of America26–29 Oct 2026
- 3rd Raw Materials for Cell & Gene Therapy SummitSan Diego, United States of America26–28 Oct 2026
- 5th Process Monitoring in Pharma Manufacturing SummitBoston, United States of America27–29 Oct 2026
- 2nd T-Cell Engager for Autoimmune Disease SummitBoston, United States of America27–29 Oct 2026